Breaking News
Get 60% Off 0
🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…
CLAIM SALE
Close

Polar Capital Funds Plc - Biotechnology Fund R Inc (0P0000ZVJJ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
37.890 +0.780    +2.10%
25/11 - Closed. Currency in GBP
Type:  Fund
Market:  United Kingdom
ISIN:  IE00B3XDCF51 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 1.97B
Polar Capital Biotechnology Fund R Income 37.890 +0.780 +2.10%

0P0000ZVJJ Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Polar Capital Biotechnology Fund R Income (0P0000ZVJJ) fund. Our Polar Capital Biotechnology Fund R Income portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 1.170 1.180 0.010
Shares 98.810 98.810 0.000
Bonds 0.020 0.020 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 20.235 19.348
Price to Book 3.536 4.050
Price to Sales 5.331 5.381
Price to Cash Flow 18.752 15.826
Dividend Yield 0.311 0.512
5 Years Earnings Growth 30.810 25.708

Sector Allocation

Name  Net % Category Average
Healthcare 100.000 99.809

Region Allocation

  • North America
  • Europe Developed
  • Developed Markets

Top Holdings

Number of long holdings: 55

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Argen-X NL0010832176 6.57 576.60 -1.81%
  Zealand Pharma DK0060257814 5.51 723.00 -2.10%
  Amgen US0311621009 5.08 280.01 -4.76%
  Vertex US92532F1003 4.40 467.12 +1.17%
  Regeneron Pharma US75886F1075 4.21 753.03 +0.47%
  Blueprint Medicines Corp US09627Y1091 4.00 94.63 +0.81%
  Celldex Therapeutics US15117B2025 3.67 26.76 -4.90%
  Rhythm Pharma US76243J1051 3.60 61.95 +3.39%
  Arcutis US03969K1088 3.31 11.51 +6.87%
  SpringWorks US85205L1070 3.17 41.22 +4.65%

Top Equity Funds by Polar Capital LLP

  Name Rating Total Assets YTD% 3Y% 10Y%
  Global Technology Fund G 7.01B 25.40 5.99 17.60
  Global Technology Fund RG 7.01B 22.55 4.25 17.14
  Global Technology Fund I G 7.01B 23.05 4.78 17.65
  Global Insurance Fund A GBP Inc 2.63B 22.10 16.32 13.34
  Global Insurance Fund B GBP Acc 2.63B 22.10 16.32 13.34
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000ZVJJ Comments

Write your thoughts about Polar Capital Funds Plc - Biotechnology Fund R Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email